TrialClinical cancer research : an official journal of the American Association for Cancer Research2026

Molecular Profiling and Tumor Biomarker Analysis of GOG281/LOGS: A Positive Late-Phase Trial of Trametinib for Recurrent/Persistent Low-Grade Serous Ovarian Carcinoma.

Robert L Hollis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.